Long-term nicotine treatment suppresses IL-1β release and attenuates substance P- and 5-HT-evoked Ca2+ responses in astrocytes

Neuroscience Letters

Volumn 553, Issue , 2013, Pages 191-195

  Westerlund, Anna ^a   Björklund, Ulrika ^a   Rönnbäck, Lars ^a   Hansson, Elisabeth ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Astrocytes; Calcium imaging; IL 1beta release; Nicotine

Indexed keywords

CALCIUM; CHOLINERGIC RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; NICOTINE; SEROTONIN; SUBSTANCE P;

ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; LONG TERM CARE; MICROVASCULAR ENDOTHELIAL CELL; NEWBORN; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT COURSE THERAPY; WESTERN BLOTTING;

ASTROCYTES; CALCIUM IMAGING; IL-1BETA RELEASE; NICOTINE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CALCIUM; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN-1BETA; MALE; MICROVESSELS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SUBSTANCE P; TIME FACTORS;

EID: 84884361797     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.038     Document Type: Article

References (18)

1. Sharma G., Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4148-4153.
2. Delbro D., Westerlund A., Björklund U., Hansson E. Inflammatory mediators have a regulating influence on nicotine receptors on astrocytes in the CNS. Neuroscience 2009, 159:770-779.
3. Pavlov V.A., Wang H., Czura C.J., Friedman S.G., Tracey K.J. The cholinergic anti-inflammatory pathway: a missing link in neuromodulation. Mol. Med. 2003, 9:125-134.
4. Gao B., Hierl M., Clarkin K., Juan T., Nguyen H., Valk M., Deng H., Guo W., Lehto S.G., Matson D., McDermott J.S., Knop J., Gaida K., Cao L., Waldon D., Albrecht B.K., Boezio A.A., Copeland K.W., Harmange J.C., Springer S.K., Malmberg A.B., McDonough S.I. Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain. Pain 2010, 149:33-49.
5. Liu Y., Hu J., Wu J., Zhu C., Hui Y., Han Y., Huang Z., Ellsworth K., Fan W. Alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J. Neuroinflammation 2012, 9:98. 10.1186/1742-2094-9-98.
6. Vallejo R., Tilley D.M., Vogel L., Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract. 2010, 10:167-184.
7. 2+ influx through TRPC3. Neurochem. Int. 2010, 57:923-934.
8. 2+ responses in inflammatory activated astrocytes co-cultured with brain endothelial cells. Neuroscience 2008, 155:1237-1249.
9. +-ATPase expression in inflammation-pretreated astrocytes. J. Neurochem. 2011, 119:686-696.
10. Takarada T., Nakamichi N., Kawagoe H., Ogura M., Fukumori R., Nakazato R., Fujikawa K., Kou M., Yoneda Y. Possible neuroprotective property of nicotinic acetylcholine receptors in association with predominant upregulation of glial cell line-derived neurotrophic factor in astrocytes. J. Neurosci. Res. 2012, 90:2074-2085.
11. Andoh T., Itoh H., Watanabe I., Sasaki T., Higashi T. Mechanisms of modulation of neuronal nicotinic receptors by substance P and OAG. Am. J. Physiol. Cell Physiol. 2001, 281:C1871-C1880.
12. Zaniewska M., McCreary A.C., Wydra K., Filip M. Differential effects of serotonin (5-HT)2 receptor targeting ligands on locomotor responses to nicotine-repeated treatment. Synapse 2010, 64:511-519.
13. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
14. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
15. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
16. Damaj M.I., Meyer E.M., Martin B.R. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 2000, 39:2785-2791.
17. Nakamura S., Saitoh M., Yamazaki M., Nishimura M., Kurashige Y., Arakawa T., Takuma T., Kaku T., Abiko Y. Nicotine induces upregulated expression of beta defensing-2 via the p38MAPK pathway in the HaCaT human keratinocyte cell line. Med. Mol. Morphol. 2010, 43:204-210.
18. Khoi P.N., Park J.S., Kim N.H., Jung Y.D. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells. Toxicol. Appl. Pharmacol. 2012, 259:248-256.